{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:16:41Z","timestamp":1785860201844,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01568-z","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:51:23Z","timestamp":1741672283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Manuscript title: unravelling the neuroprotective role of miR-27a-3p in the MAPK pathway in Parkinson's disease"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1270-7655","authenticated-orcid":false,"given":"Zahra","family":"Moradi Vastegani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4518-1506","authenticated-orcid":false,"given":"Rasoul","family":"Ghaedi-Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6748-4105","authenticated-orcid":false,"given":"Andisheh","family":"Oroujalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-5661","authenticated-orcid":false,"given":"Maryam","family":"Peymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9790-5644","authenticated-orcid":false,"given":"Kamran","family":"Ghaedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005","journal-title":"Elife"},{"key":"1568_CR2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.biopha.2017.03.100","volume":"90","author":"H Ahmed","year":"2017","unstructured":"Ahmed H, Abushouk AI, Gabr M, Negida A, Abdel-Daim MM (2017) Parkinson\u2019s disease and pesticides: a meta-analysis of disease connection and genetic alterations. Biomed Pharmacother 90:638\u2013649","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1568_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6895.1000298","volume":"4","author":"G Ayano","year":"2016","unstructured":"Ayano G (2016) Parkinson\u2019s disease: a concise overview of etiology, epidemiology, diagnosis, comorbidity and management. J Neurol Disord 4(6):1\u20136","journal-title":"J Neurol Disord"},{"key":"1568_CR4","doi-asserted-by":"crossref","unstructured":"Azam S, Haque ME, Cho D-Y, Kim J-S, Jakaria M, Kim I-S, Choi D-K (2022) Dioscin-mediated autophagy alleviates MPP+-induced neuronal degeneration: an in vitro parkinson&rsquo;s disease model. Molecules 27(9):2827. https:\/\/www.mdpi.com\/1420-3049\/27\/9\/2827","DOI":"10.3390\/molecules27092827"},{"issue":"1","key":"1568_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27(1):27\u201342. https:\/\/doi.org\/10.1111\/ene.14108","journal-title":"Eur J Neurol"},{"issue":"11","key":"1568_CR6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1357-2725(01)00093-0","volume":"33","author":"RK Barr","year":"2001","unstructured":"Barr RK, Bogoyevitch MA (2001) The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 33(11):1047\u20131063","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"1568_CR7","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms19102973","volume":"19","author":"A Bohush","year":"2018","unstructured":"Bohush A, Niewiadomska G, Filipek A (2018) Role of mitogen activated protein kinase signaling in Parkinson\u2019s disease. Int J Mol Sci 19(10):2973","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1568_CR8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4161\/cc.3.4.821","volume":"3","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Green DR (2004) Cytoplasmic p53: bax and forward. Cell Cycle 3(4):427\u2013429","journal-title":"Cell Cycle"},{"issue":"1","key":"1568_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1196\/annals.1299.124","volume":"1010","author":"C Colombo","year":"2003","unstructured":"Colombo C, Cosentino M, Marino F, Rasini E, Ossola M, Blandini F, Mangiagalli A, Samuele A, Ferrari M, Bombelli R (2003) Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson\u2019s disease. Ann N Y Acad Sci 1010(1):679\u2013682","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1568_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/archneur.62.3.353","volume":"62","author":"JL Eriksen","year":"2005","unstructured":"Eriksen JL, Wszolek Z, Petrucelli L (2005) Molecular pathogenesis of Parkinson disease. Arch Neurol 62(3):353\u2013357. https:\/\/doi.org\/10.1001\/archneur.62.3.353","journal-title":"Arch Neurol"},{"key":"1568_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neures.2023.12.001","volume":"203","author":"MM Esfahani","year":"2024","unstructured":"Esfahani MM, Mostashfi M, Hosseinabadi SV, Hashemi MS, Peymani M, Zohrabi D, Ghaedi K (2024) Unveiling the regulatory of miR-101\u20133p on ZNF746 in a Parkinson\u2019s disease cell model: Implications for therapeutic targeting. Neurosci Res 203:18\u201327","journal-title":"Neurosci Res"},{"issue":"12","key":"1568_CR12","doi-asserted-by":"crossref","first-page":"e0244776","DOI":"10.1371\/journal.pone.0244776","volume":"15","author":"S Fazeli","year":"2020","unstructured":"Fazeli S, Motovali-Bashi M, Peymani M, Hashemi M-S, Etemadifar M, Hossein Nasr-Esfahani M, Ghaedi K (2020) Correction: a compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson\u2019s patients is associated with the early stage onset of disease. PLoS ONE 15(12):e0244776","journal-title":"PLoS ONE"},{"key":"1568_CR13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1134\/S0006297912080020","volume":"77","author":"E Filatova","year":"2012","unstructured":"Filatova E, Alieva AK, Shadrina M, Slominsky P (2012) MicroRNAs: possible role in pathogenesis of Parkinson\u2019s disease. Biochem Mosc 77:813\u2013819","journal-title":"Biochem Mosc"},{"key":"1568_CR14","unstructured":"Forno LS (1987) The Lewy body in Parkinson's disease. Adv Neurol 45:35\u201343. http:\/\/europepmc.org\/abstract\/MED\/3030070"},{"issue":"5","key":"1568_CR15","first-page":"4431","volume":"14","author":"P Gong","year":"2017","unstructured":"Gong P, Deng F, Zhang W, Ji J, Liu J, Sun Y, Hu J (2017) Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson\u2019s disease by oxidative stress inhibition. Exp Ther Med 14(5):4431\u20134437","journal-title":"Exp Ther Med"},{"issue":"1","key":"1568_CR16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/tnsci-2018-0022","volume":"9","author":"J He","year":"2018","unstructured":"He J, Zhong W, Zhang M, Zhang R, Hu W (2018) P38 mitogen-activated protein kinase and Parkinson\u2019s disease. Transl Neurosci 9(1):147\u2013153","journal-title":"Transl Neurosci"},{"issue":"1","key":"1568_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-021-02518-9","volume":"22","author":"L He","year":"2022","unstructured":"He L, Chen Z, Wang J, Feng H (2022) Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer\u2019s disease. BMC Neurol 22(1):1\u20138","journal-title":"BMC Neurol"},{"issue":"5536","key":"1568_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/258612a0","volume":"258","author":"MR Issidorides","year":"1975","unstructured":"Issidorides MR, Stefanis CN, Varsou E, Katsorchis T (1975) Altered chromatin ultrastructure in neutrophils of schizophrenics. Nature 258(5536):612\u2013614","journal-title":"Nature"},{"issue":"D1","key":"1568_CR19","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45(D1):D353\u2013D361","journal-title":"Nucleic Acids Res"},{"key":"1568_CR46","doi-asserted-by":"crossref","unstructured":"Kim J, Fiesel FC, Belmonte KC, Hudec R, Wang WX, Kim C, Nelson PT, Springer W, Kim J (2016) miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol Neurodegener 11(1):55","DOI":"10.1186\/s13024-016-0121-4"},{"issue":"4","key":"1568_CR20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ng865","volume":"30","author":"EC Lai","year":"2002","unstructured":"Lai EC (2002) Micro RNAs are complementary to 3\u2032 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30(4):363\u2013364","journal-title":"Nat Genet"},{"issue":"6","key":"1568_CR21","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/med.21718","volume":"40","author":"D Li","year":"2020","unstructured":"Li D, Mastaglia FL, Fletcher S, Wilton SD (2020) Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson\u2019s disease in the precision medicine era. Med Res Rev 40(6):2650\u20132681","journal-title":"Med Res Rev"},{"key":"1568_CR22","doi-asserted-by":"crossref","unstructured":"Lindqvist D, Kaufman E, Brundin L, Hall S, Surova Y, Hansson O (2012) Non-motor symptoms in patients with Parkinson\u2019s disease\u2013correlations with inflammatory cytokines in serum. PLoS One 7(10):e47387","DOI":"10.1371\/journal.pone.0047387"},{"issue":"5","key":"1568_CR23","first-page":"1284","volume":"10","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhang J, Jiang M, Cai Q, Fang J, Jin L (2018) MANF improves the MPP+\/MPTP-induced Parkinson\u2019s disease via improvement of mitochondrial function and inhibition of oxidative stress. Am J Trans Res 10(5):1284","journal-title":"Am J Trans Res"},{"issue":"11","key":"1568_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11033-016-4054-3","volume":"43","author":"M Majidinia","year":"2016","unstructured":"Majidinia M, Mihanfar A, Rahbarghazi R, Nourazarian A, Bagca B, Avci \u00c7B (2016) The roles of non-coding RNAs in Parkinson\u2019s disease. Mol Biol Rep 43(11):1193\u20131204. https:\/\/doi.org\/10.1007\/s11033-016-4054-3","journal-title":"Mol Biol Rep"},{"issue":"9","key":"1568_CR25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","volume":"16","author":"TN Martinez","year":"2012","unstructured":"Martinez TN, Greenamyre JT (2012) Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease. Antioxid Redox Signal 16(9):920\u2013934","journal-title":"Antioxid Redox Signal"},{"key":"1568_CR26","doi-asserted-by":"crossref","first-page":"120650","DOI":"10.1016\/j.lfs.2022.120650","volume":"303","author":"AV Motlagh","year":"2022","unstructured":"Motlagh AV, Mahdevar M, Mirzaei S, Entezari M, Hashemi M, Hushmandi K, Peymani M (2022) Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity. Life Sci 303:120650","journal-title":"Life Sci"},{"key":"1568_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2013.11.007","volume":"63","author":"E Mutez","year":"2014","unstructured":"Mutez E, Nkiliza A, Belarbi K, de Broucker A, Vanbesien-Mailliot C, Bleuse S, Duflot A, Comptdaer T, Semaille P, Blervaque R (2014) Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson\u2019s disease. Neurobiol Dis 63:165\u2013170","journal-title":"Neurobiol Dis"},{"key":"1568_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-7091-6284-2_12","volume":"7","author":"T Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Cytokines in Parkinson\u2019s disease. Adv Res Neurodegener 7:143\u2013151","journal-title":"Adv Res Neurodegener"},{"issue":"12","key":"1568_CR29","doi-asserted-by":"crossref","first-page":"e51111","DOI":"10.1371\/journal.pone.0051111","volume":"7","author":"M Narasimhan","year":"2012","unstructured":"Narasimhan M, Patel D, Vedpathak D, Rathinam M, Henderson G, Mahimainathan L (2012) Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS ONE 7(12):e51111","journal-title":"PLoS ONE"},{"issue":"8","key":"1568_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/15257770.2021.1944637","volume":"40","author":"A Oroujalian","year":"2021","unstructured":"Oroujalian A, Peymani M, Ghaedi K (2021) rs73092672 allele T is significantly associated with the higher risk of breast cancer incidence. Nucleosides Nucleotides Nucleic Acids 40(8):779\u2013789. https:\/\/doi.org\/10.1080\/15257770.2021.1944637","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"1568_CR31","doi-asserted-by":"publisher","unstructured":"Oroujalian A, Peymani M (2022). Chapter 16 - MicroRNAs in cardiovascular diseases. In: Xiao J (Ed.), MicroRNA. Academic Press, pp 307\u2013315. https:\/\/doi.org\/10.1016\/B978-0-323-89774-7.00030-3","DOI":"10.1016\/B978-0-323-89774-7.00030-3"},{"key":"1568_CR32","doi-asserted-by":"crossref","unstructured":"Oroujalian A, Peymani M (2022). Maturation of microRNAs. In: MicroRNA. Elsevier, pp 19\u201330","DOI":"10.1016\/B978-0-323-89774-7.00010-8"},{"key":"1568_CR33","first-page":"175883591987557","volume":"11","author":"JG Park","year":"2019","unstructured":"Park JG, Aziz N, Cho JY (2019) MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target. Ther Adv Med Oncol 11:1758835919875574","journal-title":"Ther Adv Med Oncol"},{"key":"1568_CR34","first-page":"1619","volume":"9","author":"A Plotnikov","year":"1813","unstructured":"Plotnikov A, Zehorai E, Procaccia S (1813) Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim et Biophys Acta (BBA)-Mol Cell Res 9:1619\u20131633","journal-title":"Biochim et Biophys Acta (BBA)-Mol Cell Res"},{"issue":"11","key":"1568_CR35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bbadis.2009.08.014","volume":"1792","author":"B Sch\u00fcle","year":"2009","unstructured":"Sch\u00fcle B, Pera RAR, Langston JW (2009) Can cellular models revolutionize drug discovery in Parkinson\u2019s disease? Biochim et Biophys Acta (BBA)-Molec Basis Dis 1792(11):1043\u20131051","journal-title":"Biochim et Biophys Acta (BBA)-Molec Basis Dis"},{"issue":"13","key":"1568_CR36","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/mds.25260","volume":"27","author":"TB Sherer","year":"2012","unstructured":"Sherer TB, Chowdhury S, Peabody K, Brooks DW (2012) Overcoming obstacles in Parkinson\u2019s disease. Mov Disord 27(13):1606\u20131611","journal-title":"Mov Disord"},{"key":"1568_CR37","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00221-017-4989-1","volume":"235","author":"A Singh","year":"2017","unstructured":"Singh A, Sen D (2017) MicroRNAs in Parkinson\u2019s disease. Exp Brain Res 235:2359\u20132374","journal-title":"Exp Brain Res"},{"key":"1568_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-016-0053-5","volume":"5","author":"SS S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen SS, Nygaard A-B, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia\u2013an exploratory study. Transl Neurodegener 5:1\u201312","journal-title":"Transl Neurodegener"},{"issue":"10","key":"1568_CR39","doi-asserted-by":"crossref","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N (2018) miRWalk: an online resource for prediction of microRNA binding sites. PLoS ONE 13(10):e0206239","journal-title":"PLoS ONE"},{"issue":"D1","key":"1568_CR40","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P (2019) STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613","journal-title":"Nucleic Acids Res"},{"key":"1568_CR41","unstructured":"Tinelli M, Kanavos P, Grimaccia F (2016) The value of early diagnosis and treatment in Parkinson's disease: a literature review of the potential clinical and socioeconomic impact of targeting unmet needs in Parkinson\u2019s disease. The London school of economics and political science (LSE)"},{"issue":"11","key":"1568_CR42","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1101\/gad.888501","volume":"15","author":"C Tournier","year":"2001","unstructured":"Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ (2001) MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15(11):1419\u20131426","journal-title":"Genes Dev"},{"issue":"5","key":"1568_CR43","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1021\/acs.jmedchem.9b00102","volume":"62","author":"P Wolle","year":"2019","unstructured":"Wolle P, Hardick J, Cronin SJ, Engel J, Baumann M, Lategahn J, Penninger JM, Rauh D (2019) Targeting the MKK7\u2013JNK (mitogen-activated protein kinase kinase 7\u2013c-Jun N-terminal kinase) pathway with covalent inhibitors. J Med Chem 62(5):2843\u20132848","journal-title":"J Med Chem"},{"issue":"08","key":"1568_CR44","first-page":"1086","volume":"123","author":"H-R Xie","year":"2010","unstructured":"Xie H-R, Hu L-S, Li G-Y (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J 123(08):1086\u20131092","journal-title":"Chin Med J"},{"key":"1568_CR45","doi-asserted-by":"crossref","unstructured":"Zahra A, Rubab I, Malik S, Khan A, Khan MJ, Fatmi MQ (2018) Meta-Analysis of miRNAs and their involvement as biomarkers in oral cancers. Biomed Res Int 2018:8439820.","DOI":"10.1155\/2018\/8439820"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01568-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01568-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01568-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T19:48:54Z","timestamp":1743104934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01568-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01568-z","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Ethics Committee of ROYAN institute and also complies with the Ethics Code of IR.ACECR.ROYAN.REC.1400.090.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"We give my consent for the publication of identifiable details within the text (\u201cMaterial\u201d) to be published in this Journal and Article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}